Results 101 to 110 of about 315,851 (243)

Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study [PDF]

open access: yes, 2006
Objective: To analyse short- and long-term outcomes and prognostic factors in a large population-based cohort of unselected patients with a first emergency admission for suspected acute coronary syndrome between 1990 and 2000 in Scotland. Methods: All
Boyd, J.   +9 more
core   +2 more sources

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro   +15 more
wiley   +1 more source

Results of Aortocoronary Bypass Surgery for Angina Pectoris [PDF]

open access: yes, 1979
To determine the relative risks and benefits of coronary bypass surgery for angina pectoris, we examined the results in our first consecutive 360 patients operated upon between May 1970 and December 1975.
Kemp, V. Eric   +3 more
core   +1 more source

Role of ivabradine in management of stable angina in patients with different clinical profiles [PDF]

open access: yes, 2018
In chronic stable angina, elevated heart rate contributes to the development of symptoms and signs of myocardial ischaemia by increasing myocardial oxygen demand and reducing diastolic perfusion time.
Camici, PG   +7 more
core   +2 more sources

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Inflammation and genetics in myo‐pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases

open access: yesESC Heart Failure, EarlyView.
Proposed management of myo‐pericardial diseases. A systematic interdisciplinary approach to myo‐pericardial disease is essential to reach a correct diagnosis, starting from multiparametric characterization including EKG, echocardiography with GLS, laboratory exams and CMR or, in case of electric or haemodynamic instability, EMB.
Marco Merlo   +18 more
wiley   +1 more source

Poor cardiovascular outcomes of underweight abdominal obesity in the entire population of newly diagnosed heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Body mass index (BMI) has been widely used as a simple tool for predicting cardiovascular risk. Here we aimed to analyse the distribution and cardiovascular outcomes according to BMI and waist circumference (WC) of the newly diagnosed heart failure (HF) patients in the entire population of the Republic of Korea for 10 years.
Joongmin Kim   +8 more
wiley   +1 more source

Recurrent angina from chronic coronary obstruction following transcatheter aortic valve implantation

open access: yesAvicenna Journal of Medicine, 2016
Severe aortic stenosis and coronary artery disease often coexist. Coronary angiography (CA) and percutaneous coronary intervention (PCI) can be challenging in patients with prior transcatheter aortic valve implantation (TAVI).
Mohamad Kabach   +3 more
doaj   +1 more source

Long‐term prognosis of pure and impure tachycardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati   +11 more
wiley   +1 more source

Guideline‐directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Among patients with ischaemic heart failure undergoing revascularisation, those receiving GDMT had lower unadjusted mortality rates. The combination of GDMT and CABG was associated with the best long‐term outcomes. In real‐world practice, the use of GDMT increased over time, reflecting a growing emphasis on guideline‐based therapy even after ...
Carlos Moliner‐Abós   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy